Recruiting Bladder Cancer Studies in Littleton
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
The objective of this study is to evaluate the efficacy and safety of sacituzumab govitecan-hziy monotherapy and with novel combinations in participants with metastatic urothelial cancer (mUC)....
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Researchers are looking for new ways to treat people with high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder but has not spread...
About Bladder Cancer Clinical Trials in Littleton
Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.
There are currently 2 bladder cancer clinical trials recruiting participants in Littleton, COLORADO. These studies are seeking a combined 1,135 participants. Research is being sponsored by Gilead Sciences, Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bladder Cancer Clinical Trials in Littleton — FAQ
Are there bladder cancer clinical trials in Littleton?
Yes, there are 2 bladder cancer clinical trials currently recruiting in Littleton, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Littleton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Littleton research site will contact you about next steps.
Are clinical trials in Littleton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Littleton studies also compensate for your time and travel.
What bladder cancer treatments are being tested?
The 2 active trials in Littleton are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.
Data updated March 2, 2026 from ClinicalTrials.gov